I’m usually also skeptical of getting excited about successful animal trials for new medications, but with this I’m actually leaning more on the side of optimism.
With cancer treatments and antivirals in mice, we’re not so much targeting the pathogen as targeting the host immune system in the hopes it ends up nerfing the intended target (tumor/virus/whatever).
Given that the compound seems effective against C. Difficile (even if it’s in mice), I’d expect it to work elsewhere.
Of course, I’m not a doctor and have no idea what I’m talking about so grain of salt required.